Neuphoria Therapeutics In...

NASDAQ: NEUP · Real-Time Price · USD
8.20
0.10 (1.23%)
At close: Aug 15, 2025, 12:08 PM

Neuphoria Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Net Income
-15.49M -21.38M -14.97M -6.53M
Depreciation & Amortization
662.99K 663.19K 763.17K 1.28M
Stock-Based Compensation
814.81K 1.35M 1.95M 983.01K
Other Working Capital
351.28K 447.29K 157.44K -294.75K
Other Non-Cash Items
-2.12M 150.97K 1.15M -2.62M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
1.46M 4.58M -3.85M 1.23M
Operating Cash Flow
-14.68M -14.64M -14.97M -5.66M
Capital Expenditures
n/a n/a -1.06K -1.1K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a -89.01K
Sales Maturities Of Investments
n/a n/a 299.68K n/a
Other Investing Acitivies
n/a 317.41K 129.06K 29.85K
Investing Cash Flow
n/a 317.41K 427.68K -60.26K
Debt Repayment
n/a -105.94K -119.85K -8.92M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
5M 105.94K -3.94M -312.17K
Financial Cash Flow
15.11M 3.86M 18.57M 23.71M
Net Cash Flow
504.99K -15.27M 3.48M 17.97M
Free Cash Flow
-14.68M -14.64M -14.97M -5.67M